Chums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management...
Posts tagged: GlaxoSmithKline
Betaville was just in the process of liasing with one of the institutional data providers for the deals numbers for this quarter to prove my own theory that the volume of announced public transactions had fallen off cliff for this period compared to previous years when: boom - Pfizer and GlaxoSmithKline announce a £10billion merger of their respective consumer healthcare businesses. Below is a link to the news:..
Anyone reading the maintream financial press could be forgiven for thinking that it's the end of the road for Greenhill, an M&A boutique that blazed a trail back in the 90s and early noughties by advising on some of the biggest takeover deals in the US and the UK.
In fact, below is a link to recent Bloomberg piece on the firm's recent demise to 52nd on the advisory league tables:..
Take a bow Dan Dunkley (who as far as I'm aware is down in New Zealand somewhere).
Dan, who Betaville had the pleasure of working with at several publications, last year revealed in The Sunday Times that GlaxoSmithKline was preparing to buy out its joint venture partner, Novartis, to get control of their consumer healthcare division. Below is a link to Dan's piece:..